Searching for smart, safe news you can TRUST?

Support safe, smart, REAL journalism. Sign up for our Axios AM & PM newsletters and get smarter, faster.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa Bay news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Charlotte news in your inbox

Catch up on the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Rebecca Zisser/Axios

After buying back more than $1 trillion of their own stock last year, public companies are slowing their share repurchases in 2019, and that will add to troubles for the market and the economy.

Why it matters: Buybacks have been a major catalyst for the market’s rise in recent years and remain an important driver of higher prices, as earnings growth has slowed and investors have become net sellers of equities.

  • With the trade war weighing on business spending and confidence, and earnings growth expected to weaken into negative territory for companies in both the second and third quarters this year, the stock market’s legs look increasingly fragile.

By the numbers: The record buyback binge in 2018 accounted for almost half of stocks' earnings-per-share growth, the largest proportion since 2007.

  • S&P reported earlier this year that Q1 2019 was the first quarter in 7 that the pace of buybacks slowed.
  • That theme has continued through the year, as the 4-week average pace of buybacks has fallen 30% from 2018’s pace as of this week, data from Bank of America Merrill Lynch shows.

What they're saying: In a recent note to clients, BAML strategists said they see late 2018 as “the turning point in this cycle of expanding debt balance sheets, buying growth and rewarding shareholders.”

  • “Investors have grown less enamored with buybacks,” Jill Carey Hall, equity and quant strategist at Bank of America Securities, tells Axios in an email. “Stocks doing the biggest buybacks had outperformed for much of the earlier part of this cycle, but over the last few years those doing the biggest buybacks have actually underperformed.”

The big picture: Companies are preparing for the economy to slow and want to pare debt and hold cash in the event of a downturn.

  • “More companies are concerned there’s a recession coming next year, and they’ve decided to preserve capital,” Bernard Baumohl, chief global economist at the Economic Outlook Group, tells Axios.
  • He argues the reduction in buybacks is a much smaller worry than the trade war, which has dampened his previously bullish outlook for the market and the overall economy.
  • In June, Baumohl said 2019 looked to be the middle of “the first game of a double header" for the economic expansion, but he now says his firm sees a 50% chance of a recession in 2020.
Buybacks are slowing, but they're not stopping
Expand chart
Data: Bloomberg, Compustat, Standard & Poor’s, FactSet, J.P. Morgan Asset Management; Chart: Axios Visuals

The buyback math is simple, David Lebovitz, global market strategist at J.P. Morgan Asset Management, tells Axios.

  • "The way to explain [less buyback spending] really comes back to what’s happening with underlying corporate profitability, and we’ve seen a pretty significant slowdown in the pace of earnings growth so far in 2019," Lebovitz says. "Because there’s less money coming through the door, the pace of buybacks has slowed."

Yes, but: This is not the death of share buybacks, by a long shot, Lebovitz adds.

  • "From a pure economic growth standpoint, last year U.S. growth was juiced by fiscal stimulus and tax cuts. That allowed us to grow well above trend. The back half of this year into next year ... we’re just not getting that gasoline poured on the fire," Lebovitz says.

The bottom line: Uncertainty about the Fed's interest rate outlook and the trade war aren't helping, either.

  • "When CFOs are looking at the next 12 months, it is kind of difficult for them to put their finger exactly on what nominal demand is going to look like, and at the same time we’re not getting that same support from fiscal policy," according to Lebovitz.

Go deeper

Dan Primack, author of Pro Rata
58 mins ago - Economy & Business

Trump blocks banks from limiting loans to gun and oil companies

Illustration: Sarah Grillo/Axios

Big banks are no longer allowed to reject business loan applicants because of the industry in which they operate, according to a new rule finalized on Thursday by the Trump administration.

Why it matters: Wall Street has curtailed its exposure to industries like guns, oil and private prisons, driven by both public and shareholder pressures. This new rule could reverse that trend.

Former FDA commissioner: "Reliable drug supply is absolutely critical"

Axios' Caitlin Owens and former FDA commissioner Mark McClellan. Photo courtesy of Axios Events

Having a reliable supply of pharmaceutical drugs throughout America will be "absolutely critical" to boosting affordability in health care during the Biden administration, former Food and Drug Administration (FDA) commissioner Mark McClellan said at a virtual Axios Event on Friday.

The big picture: McClellan, who served under President George W. Bush, says drugs having limited supply and limited competition leads to elevated pricing. He considers drug supply to be a national security and public health issue.

Felix Salmon, author of Capital
4 hours ago - Economy & Business

Americans are still spending money

Source: Census Bureau; Chart: Axios Visuals

Americans spent more money at stores and restaurants in 2020 than they did in 2019 — even in the face of a devastating global pandemic that shut down broad sectors of the economy.

Why it matters: The monthly retail sales report this morning came in well below expectations, and showed consumer spending falling on a seasonally-adjusted basis. Total expenditures were still higher in December 2020 than they were a year previously, however.